Neoantigen prediction and computational perspectives towards clinical benefit

What are antigens and neoantigens? #myelomaПодробнее

Individualized neoantigen therapies: Exploring one medicine for one patientПодробнее

Targeting Tumor Mutations for Personalized Cancer ImmunotherapyПодробнее

Accurate Prediction of Immuno-oncology Targets with a Neoantigen Discovery WorkflowПодробнее

Ranking Neoantigens for Therapeutic Cancer VaccinesПодробнее

Landscape analysis of neoepitope-specific T-cell responses depending on clinical benefit from ICIsПодробнее

Yeojun Yun: Syntekabio Bio's Use of Genomic Big Data in Neoantigen Prediction and DiscoveryПодробнее

Computational Prediction of MHC Anchor Locations Guide Neoantigen Identification & PrioritizationПодробнее

PGV_001, a neoantigen vaccine, produces promising immune responsesПодробнее

Utilizing neoantigen-specific TCRs for personalized immunotherapiesПодробнее

Genomic Medicine XVI: Host Genomics and Infectious DiseaseПодробнее

Identification of predicted neoantigen vaccine candidates in follicular lymphoma patientsПодробнее

Efficient Selection of Tumor Associated Neoantigens in the Design of Personalized Cancer VaccinesПодробнее

Optimizing public neoantigen-targeting immunotherapiesПодробнее

STAT115 Chapter 26.2 HLA and Neoantigen PresentationПодробнее

2021 Neoantigen Summit EU Maik PruessПодробнее

Meet Our Team: Neoantigen Science GroupПодробнее

Neoantigens for melanoma treatmentПодробнее

Andrew Allen, Gritstone Oncology on Cancer Neoantigen VaccinesПодробнее